The cost of health care for patients with sickle cell disease

American Journal of Hematology

Volumn 84, Issue 6, 2009, Pages 320-322

  Ballas, Samir K ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

BETA THALASSEMIA; BONE MARROW TRANSPLANTATION; CHRONIC PAIN; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; EMERGENCY CARE; EMERGENCY WARD; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; MEDICAID; MEDICAL FEE; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT; SICKLE CELL ANEMIA; STEM CELL TRANSPLANTATION;

ANEMIA, SICKLE CELL; HEALTH CARE COSTS; HUMANS;

EID: 66849102133     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21443     Document Type: Note

References (12)

1. Ballas SK. Bone-marrow transplantation in sickle-cell anemia: Why so few so late? Lancet 1992;340:1226.
2. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644. (Pubitemid 124005049)
3. Yang YM, Shah AK, Watson M, Mankad VN. Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients. Public Health Reports 1995;110:80-86.
4. Davis H, Moore RM Jr, Gergen PJ. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep 1997;112:40-43. (Pubitemid 27053113)
5. Woods K, Karrison T, Koshy M, et al. Hospital utilization patterns and costs for adult sickle cell patients in Illinois. Public Health Reports 1997;112:44-51. (Pubitemid 27053114)
6. Bilenker JH, Weller WE, Shaffer TJ, et al. The costs of children with sickle cell anemia: Preparing for managed care. J Pediatr Hematol Oncol 1998;20: 528-533. (Pubitemid 29135817)
7. Lanzkron S, Haywood C Jr, Segal JB, Dover GJ. Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea. Am J Hematol 2006;81:927-932. (Pubitemid 44864450)
8. National Heart Lung and Blood Institute.The Management of Sickle Cell Disease. NIH Publication 02-2117. 2002.
9. Nietert PJ, Abboud MR, Zoller JS, Silverstein MD. Costs, charges, and reimbursements for persons with sickle cell disease. J Pediatr Hematol Oncol 1999;21:389-396. (Pubitemid 30306008)
10. Ballas SK, Smith ED. Red blood cell changes during the evolution of the sickle cell painful crisis. Blood 1992;79:2154-2163.
11. Ballas SK, Lusardi M. Hospital readmission for adult acute sickle cell painful episodes: Frequency, etiology, and prognostic significance. Am J Hematol 2005;79:17-25. (Pubitemid 40604787)
12. Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG. The cost of health care for children and adults with sickle cell disease. Am J Hematol 10.1002/ajh.21443.